|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.46 USD | +3.55% |
|
-7.94% | -21.20% |
| 05-13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
| 05-08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Biodesix, Inc. reaffirmed revenue guidance for the year 2022. For the year, company expects to generate between $37.5 million and $39.5 million in total revenue in 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -21.20% | 162M | |
| -23.07% | 8.1B | |
| +67.53% | 4.26B | |
| +1.88% | 2.57B | |
| -8.06% | 2.49B | |
| -41.95% | 2.39B | |
| -12.05% | 1.77B | |
| -21.45% | 1.53B | |
| +17.44% | 1.2B | |
| -43.89% | 1.18B |
BIODESIX, INC. 
